Open AccessSuccessful Switch to Tacrolimus in a Patient with Pseudotumor Cerebri Following Cyclosporine a Treatment in Renal Transplantation
Author(s) -
Lee Sang Joon,
Jung Yeon Soon,
Rim Hark,
Yoo Bong Goo
Publication year - 2009
Publication title -
dialysis & transplantation
Language(s) - English
Resource type - Journals
eISSN - 1932-6920
pISSN - 0090-2934
DOI - 10.1002/dat.20361
Subject(s) - medicine , tacrolimus , pseudotumor cerebri , papilledema , transplantation , surgery , renal transplant , intracranial pressure
We report a case involving a 26‐year‐old Asian woman who developed pseudotumor cerebri (PTC) 2 years after renal transplantation. Cyclosporine A (CsA) was the only medication with a known neurotoxic side effect among her medications. CsA was discontinued and substituted with tacrolimus. After the CsA had been stopped, the elevated intracranial pressure gradually decreased and the bilateral papilledema finally normalized within 6 months. The case described herein is the first case of PTC that improved after renal transplantation by switching from CsA to tacrolimus.